(Q28174122)

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

Clinical features and diagnosis of aspirin induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

Nasal polyps in asthma and rhinitis. A review of 6,037 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

A controlled study of 9α,11β-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

5' flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

Aspirin-induced asthma: advances in pathogenesis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

Report of the INTERASMA Working Group on Standardization of Inhalation Provocation Tests in Aspirin-induced Asthma. Oral and inhalation provocation tests for the diagnosis of aspirin-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

The safety of celecoxib in patients with aspirin-sensitive asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

NSAID-sensitive patients tolerate rofecoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

A randomized controlled study evaluating medical treatment versus surgical treatment in addition to medical treatment of nasal polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X

Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00801.X